The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of molecular screening for FGFR alterations (alts) in the RAGNAR histology-agnostic study with the FGFR-inhibitor (FGFRi) erdafitinib.
 
Christophe Massard
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Debiopharm Group; Faron Pharmaceuticals; Genentech/Roche; Innate Pharma; Ipsen; Janssen; Lilly; MSD; Novartis; Orion; Pfizer; PharmaMar; Sanofi; Taiho Pharmaceutical
 
Shubham Pant
Honoraria - 4D Pharma
Consulting or Advisory Role - TYME; Xencor; Zymeworks
Research Funding - ArQule (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Onco Response (Inst); RedHill Biopharma (Inst); Rgenix (Inst); Sanofi/Aventis (Inst); Xencor (Inst)
 
Gopa Iyer
Consulting or Advisory Role - Basilea; Bayer; Janssen; Mirati Therapeutics
Research Funding - Bayer (Inst); Debiopharm Group (Inst); Mirati Therapeutics (Inst); Novartis (Inst)
 
Martin H. Schuler
Honoraria - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Roche Pharma AG
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; MorphoSys; Novartis; Roche; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Highly sensitive method for mutation detection by PCR (Inst)
 
Olaf Witt
Consulting or Advisory Role - AstraZeneca; Bayer; BMS; Day One Therapeutics; Janssen Research & Development; Novartis; Roche
Research Funding - BioMed Valley Discoveries (Inst)
 
Shukui Qin
No Relationships to Disclose
 
Josep Tabernero
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Avvinity; Bayer; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; F. Hoffmann LaRoche; Genentech; HalioDx; Hutchison MediPharma; Ikena Oncology; IQvia; Lilly; Menarini; Merck Serono; Merus; Mirati Therapeutics; MSD; Neophore; Novartis; Orion Biotechnology; Peptomyc; Pfizer; Pierre Fabre; Samsung Bioepis; Sanofi; Seagen; Servier; Taiho Pharmaceutical; Tessa Therapeutics; TheraMyc
Other Relationship - Imedex; Medscape; MJH Life Sciences; Peerview; Physicans' Education Resource
 
Toshihiko Doi
Honoraria - Abbvie; Astellas Pharma; Bristol-Myers Squibb Japan; Oncolys BioPharma; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; Amgen; Bayer; Boehringer Ingelheim; Daiichi Sankyo; MSD; Novartis; Otsuka; Rakuten Medical; Sumitomo Dainippon; Taiho Pharmaceutical; Takeda
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Quintiles (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst)
 
Darren R. Hargrave
Honoraria - Bayer
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Janssen; Lilly; Novartis; PureTech; Roche/Genentech; SomaNautix
Research Funding - AstraZeneca
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Novartis; Roche/Genentech
Other Relationship - Abbvie; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Epizyme; Janssen; Novartis
 
Constance Hammond
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Shonda Marie Little
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Qi Xia
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Jing Cao
Employment - Janssen Research & Development
 
Ademi E. Santiago-Walker
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Hussein Sweiti
Employment - Janssen Research & Development